Status: Not yet recruiting
A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated Triglycerides
This is a phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics effects of a single dose of FXR0906 injection or placebo in Chinese healthy adult volunteers with or without TG increase.
Participants needed: 24
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd.Updated: Aug 14, 2026Locations: 1
Eligibility criteria
History or presence of clinically significant diseases/abnormality, or with clin... [+5]